Mortensen Eric R. 4
4 · Cytosorbents Corp · Filed Mar 20, 2018
Insider Transaction Report
Form 4
Mortensen Eric R.
Chief Medical Officer
Transactions
- Award
Common Stock
2018-03-15+20,000→ 36,500 total - Award
Stock Option (right to buy)
2018-03-15+80,000→ 80,000 totalExercise: $7.90Exp: 2028-03-15→ Common Stock (80,000 underlying)
Footnotes (3)
- [F1]These shares represent restricted stock units ("RSUs") that will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation (the "Company"), as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan").
- [F2]Includes (i) 20,000 RSUs granted on March 15, 2018 and reported on this Form 4, (ii) 14,000 RSUs granted on February 28, 2018, and subject to vesting as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and that will be settled into common stock upon vesting, and (iii) 2,500 shares of common stock owned by the reporting person.
- [F3]Such options were granted pursuant to the Plan, and shall vest upon achievement of certain performance goals as determined in the discretion of the Board of Directors of the Company.